A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation

Transplantation

Volumn 61, Issue 7, 1996, Pages 1029-1037

  Keown, Paul ^a   Häyry, Pekka ^c   Morris, Peter ^d   Stiller, Calvin ^j   Barker, Chris ^v   Carr, Lisa ^v   Landsberg, David ^a   Hardie, Ian ^b   Rigby, Russell ^b   Isoniemi, Helena ^c   Gray, Derek ^d   Belitsky, Philip ^e   McDonald, Allan ^e   Mathew, Tim ^f   Clarkson, A ^f   Barratt, L ^f   Buchholz, B ^g   Walker, Rowan ^h   Kirste, Günther ⁱ   Muirhead, Norman ^j   Tiller, David ^k   Duggin, Geoff ^k   Halloran, Philip ^l   Daloze, Pierre ^m   St Louis, Gilles ^m   Russell, David ⁿ   Ludwin, David ⁿ   Vialtel, P ^o   Binswanger, U ^p   Buckels, J A C ^q   Touraine, Jean Louis ^r   Hickey, David ^s   Remuzzi, Giuseppe ^t   Locatelli, Giuseppe ^t   Lam, F T ^u   Tapper, Ed ^v   more..

^a British Columbia Transplant Society   (Canada)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^f QUEEN ELIZABETH HOSPITAL   (Australia)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ University Department of Surgery   (Germany)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

^k ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^l UNIVERSITY OF ALBERTA   (Canada)

^m NOTRE DAME HOSPITAL   (Canada)

ⁿ ST JOSEPH S HOSPITAL   (Canada)

^o UNIV GRENOBLE ALPES   (France)

^p Medizinische Klinik Zurich   (Switzerland)

^q QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^r EDOUARD HERRIOT HOSPITAL   (France)

^s BEAUMONT HOSPITAL   (Ireland)

^t MARIO NEGRI INST PHARMACOL RES   (Italy)

^u WALSGRAVE HOSPITAL   (United Kingdom)

^v ROCHE BIOSCIENCE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADULT; AGED; AZATHIOPRINE; CADAVER; DOUBLE-BLIND METHOD; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES;

EID: 0006986048     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00008     Document Type: Article

References (20)

1. Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
2. Koyama H, Cecka JM. Rejection episodes. Clin Transpl 1992; 391.
3. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 307.
4. Almond PS, Matas AJ, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
5. Tesi RJ, Henry ML, Elkammas EA, Ferguson RM. Predictors of long-term primary cadaveric renal transplant survival. Clin Transpl 1993; 7: 345.
6. Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 1.
7. Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1659.
8. Platz KP, Sollinger HW, Hullert DA, Eckhoff DE, Eugui EM, Allison AC. RS-61443 - a new, potent immunosuppressive agent. Transplantation 1990; 51: 27.
9. Morris RE, Wang J, Blum JR, et al. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 1991; 23 (suppl 2): 19.
10. Platz KP, Bechstein WO, Eckhoff DE, Susuki Y, Sollinger HW. RS-61443 reverses acute rejection in dogs. Surgery 1991; 110: 736.
11. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
12. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons, 1981.
13. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 4: 800.
14. United States Food and Drug Administration. "COSTART" coding symbols for thesaurus of adverse reaction terms, 3rd ed. Rockville, MD: USFDA, 1989.
15. Koch G, Carr G, Amana I, Stokes M, Uryniak T. Categorical data analysis. In: Berry DA, ed. Statistical methodology in the pharmaceutical sciences. New York: Dekker, 1990: 389.
16. SAS Institute, Inc. Software release 6.08. Cary, NC: SAS, 1989.
17. BMDP Statistical Software Inc. Software release. Los Angeles: BMDP, 1990.
18. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplantation lymphoproliferative disorders occurring in the setting of cyclosporine and prednisone immunosuppression. Am J Pathol 1988; 133: 173.
19. Sheil AG, Disney AP, Mathew TG, Amiss N, Excell L. Malignancy following renal transplantation. Transplant Proc 1992; 24: 1946.
20. Gregory CR, Pratt RE, Huie P, et al. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc 1993; 25: 770.